CytRx Corporation (CYTR) Appoints Shanta Chawla, M.D. As Vice President, Clinical Development
1/16/2014 7:24:08 AM
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the appointment of Shanta Chawla, M.D. as Vice President, Clinical Development. Dr. Chawla has more than 13 years of clinical research, operations and development experience, with a focus on oncology therapeutics.
Help employers find you! Check out all the jobs and post your resume.
comments powered by